These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 794724)
21. Clinical outcome with naltrexone. Resnick RB; Washton AM Ann N Y Acad Sci; 1978; 311():241-7. PubMed ID: 283722 [No Abstract] [Full Text] [Related]
22. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program. Schecter A; Kauders F Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302 [No Abstract] [Full Text] [Related]
23. Clinical experience with naltrexone. O'Brien CP; Greenstein RA; Mintz J; Woody GE Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298 [No Abstract] [Full Text] [Related]
24. Naltrexone: the clinical investigator's dilemma. Ling W NIDA Res Monogr; 1978; (19):308-14. PubMed ID: 106297 [No Abstract] [Full Text] [Related]
25. Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare. Rawson RA; Washton AM; Resnick RB; Tennant FS NIDA Res Monogr; 1981 Feb; 34():101-8. PubMed ID: 6783916 [No Abstract] [Full Text] [Related]
26. Factors influencing success in an antagonistic treatment program. Parwatikar S; Crawford J; Nelkupa JV; De Gracia C NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725 [No Abstract] [Full Text] [Related]
27. Naltrexone in a behavioral treatment program. O'Brien C; Greenstein R NIDA Res Monogr; 1976 Sep; (9):136-40. PubMed ID: 63915 [No Abstract] [Full Text] [Related]
28. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison. Judson BA; Carney TM; Goldstein A Drug Alcohol Depend; 1981 Jul; 7(4):325-46. PubMed ID: 7023894 [TBL] [Abstract][Full Text] [Related]
31. NIDA's naltrexone research program. Julius D NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943 [No Abstract] [Full Text] [Related]
32. Abstinence treatments for opiate addicts: therapeutic community or naltrexone? Arndt I; McLellan AT; O'Brien CP NIDA Res Monogr; 1984 Mar; 49():275-81. PubMed ID: 6434972 [No Abstract] [Full Text] [Related]
33. Action of naloxone and naltrexone in different types of psychoses. Volavka J Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726 [No Abstract] [Full Text] [Related]
34. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers. Judson BA; Goldstein A Drug Alcohol Depend; 1982; 10(2-3):269-82. PubMed ID: 7166139 [TBL] [Abstract][Full Text] [Related]
35. The double-blind crossover trial design: how good is it for psychoactive drugs? Brahen LS; Capone T; Wojak JC Am J Drug Alcohol Abuse; 1979; 6(2):189-96. PubMed ID: 517491 [No Abstract] [Full Text] [Related]
37. Experiences with Naltrexone in Buffalo. Taintor Z; Landsberg R; Wicks N Am J Drug Alcohol Abuse; 1975; 2(3-4):391-401. PubMed ID: 775969 [No Abstract] [Full Text] [Related]
38. Naltrexone in chronic schizophrenia. Results of a clinical trial. Ragheb M; Berney S; Ban T Int Pharmacopsychiatry; 1980; 15(1):1-5. PubMed ID: 6993401 [TBL] [Abstract][Full Text] [Related]
39. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal]. Patricio LD; Miguel N Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010 [No Abstract] [Full Text] [Related]